A ceiling “maximum fair price” established by the Inflation Reduction Act will end up being an important driver of ...

Penn State sues insulin makers and PBMs alleging inflated prices and seeks damages for overpayments in its self-insured health plans.

RFK Jr. says TrumpRX will launch "probably in the next 10 days." What we know about how buying medicine, getting discounts on ...

Three U.S. senators sent a letter to the HHS Office of Inspector General raising questions about TrumpRx — whose structure ...

With approximately 400 independent pharmacies in Louisiana, many are voicing concern about "unfair" dispensing fees set by ...

President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices ...

Four specs wearers spent weeks ordering and testing frames to find the best online prescription glasses in 2026. See the five retailers we recommend.

Attorney General Brenna Bird has filed a lawsuit against 18 Pharmacy Benefit Managers (PBMs) and insulin manufacturers, accusing them of inflating insulin prices and profiting at ...

The Pennsylvania State University has filed a federal lawsuit accusing major insulin manufacturers and pharmacy benefit ...

Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of federal price negotiations that could lower prices for Medicare patients.

The Centers for Medicare & Medicaid Services yesterday announced 15 drugs under Medicare Parts D and B selected for the third round of price negotiations. Negotiations will occur this year and any ...

Medicare selected Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...